These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 20110571)
1. Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Nobécourt E; Tabet F; Lambert G; Puranik R; Bao S; Yan L; Davies MJ; Brown BE; Jenkins AJ; Dusting GJ; Bonnet DJ; Curtiss LK; Barter PJ; Rye KA Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):766-72. PubMed ID: 20110571 [TBL] [Abstract][Full Text] [Related]
2. The 5A apolipoprotein A-I mimetic peptide displays antiinflammatory and antioxidant properties in vivo and in vitro. Tabet F; Remaley AT; Segaliny AI; Millet J; Yan L; Nakhla S; Barter PJ; Rye KA; Lambert G Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):246-52. PubMed ID: 19965776 [TBL] [Abstract][Full Text] [Related]
3. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Nicholls SJ; Dusting GJ; Cutri B; Bao S; Drummond GR; Rye KA; Barter PJ Circulation; 2005 Mar; 111(12):1543-50. PubMed ID: 15781735 [TBL] [Abstract][Full Text] [Related]
4. The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Di Bartolo BA; Nicholls SJ; Bao S; Rye KA; Heather AK; Barter PJ; Bursill C Atherosclerosis; 2011 Aug; 217(2):395-400. PubMed ID: 21571275 [TBL] [Abstract][Full Text] [Related]
5. Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Puranik R; Bao S; Nobecourt E; Nicholls SJ; Dusting GJ; Barter PJ; Celermajer DS; Rye KA Atherosclerosis; 2008 Jan; 196(1):240-247. PubMed ID: 17586510 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Patel S; Di Bartolo BA; Nakhla S; Heather AK; Mitchell TW; Jessup W; Celermajer DS; Barter PJ; Rye KA Atherosclerosis; 2010 Oct; 212(2):392-7. PubMed ID: 20609437 [TBL] [Abstract][Full Text] [Related]
7. High-density lipoproteins inhibit vascular endothelial inflammation by increasing 3β-hydroxysteroid-Δ24 reductase expression and inducing heme oxygenase-1. Wu BJ; Chen K; Shrestha S; Ong KL; Barter PJ; Rye KA Circ Res; 2013 Jan; 112(2):278-88. PubMed ID: 23123430 [TBL] [Abstract][Full Text] [Related]
8. The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit. Di Bartolo BA; Vanags LZ; Tan JT; Bao S; Rye KA; Barter PJ; Bursill CA Lipids Health Dis; 2011 Nov; 10():224. PubMed ID: 22128776 [TBL] [Abstract][Full Text] [Related]
9. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. Baker PW; Rye KA; Gamble JR; Vadas MA; Barter PJ J Lipid Res; 1999 Feb; 40(2):345-53. PubMed ID: 9925665 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Vascular Inflammation by Apolipoprotein A-IV. Shearston K; Tan JTM; Cochran BJ; Rye KA Front Cardiovasc Med; 2022; 9():901408. PubMed ID: 35845068 [TBL] [Abstract][Full Text] [Related]
12. Lysine glycation of apolipoprotein A-I impairs its anti-inflammatory function in type 2 diabetes mellitus. Liu D; Ji L; Zhao M; Wang Y; Guo Y; Li L; Zhang D; Xu L; Pan B; Su J; Xiang S; Pennathur S; Li J; Gao J; Liu P; Willard B; Zheng L J Mol Cell Cardiol; 2018 Sep; 122():47-57. PubMed ID: 30092227 [TBL] [Abstract][Full Text] [Related]
13. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties. Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753 [TBL] [Abstract][Full Text] [Related]
14. Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells. McGrath KC; Li XH; Puranik R; Liong EC; Tan JT; Dy VM; DiBartolo BA; Barter PJ; Rye KA; Heather AK Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):877-82. PubMed ID: 19325144 [TBL] [Abstract][Full Text] [Related]
15. The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Nobecourt E; Davies MJ; Brown BE; Curtiss LK; Bonnet DJ; Charlton F; Januszewski AS; Jenkins AJ; Barter PJ; Rye KA Diabetologia; 2007 Mar; 50(3):643-53. PubMed ID: 17216278 [TBL] [Abstract][Full Text] [Related]
16. Human plasminogen kringle 1-5 reduces atherosclerosis and neointima formation in mice by suppressing the inflammatory signaling pathway. Chang PC; Wu HL; Lin HC; Wang KC; Shi GY J Thromb Haemost; 2010 Jan; 8(1):194-201. PubMed ID: 19874473 [TBL] [Abstract][Full Text] [Related]
17. Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein A-I. Nobécourt E; Zeng J; Davies MJ; Brown BE; Yadav S; Barter PJ; Rye KA Diabetologia; 2008 Jun; 51(6):1008-17. PubMed ID: 18437350 [TBL] [Abstract][Full Text] [Related]
18. Human apolipoprotein A-I exerts a prophylactic effect on high-fat diet-induced atherosclerosis via inflammation inhibition in a rabbit model. Li J; Wang W; Han L; Feng M; Lu H; Yang L; Hu X; Shi S; Jiang S; Wang Q; Ye L Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):149-158. PubMed ID: 28069582 [TBL] [Abstract][Full Text] [Related]
19. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809 [TBL] [Abstract][Full Text] [Related]
20. Cuban Sugar Cane Wax Alcohol Exhibited Enhanced Antioxidant, Anti-Glycation and Anti-Inflammatory Activity in Reconstituted High-Density Lipoprotein (rHDL) with Improved Structural and Functional Correlations: Comparison of Various Policosanols. Cho KH; Baek SH; Nam HS; Kim JE; Kang DJ; Na H; Zee S Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]